Process for preparing a phenylalanine derivative and intermediates thereof
The present invention provides a process for preparing a novel phenylalanine derivative of the formula (I): wherein X1 is a halogen atom, X2 is a halogen atom, Q is a group of the formula —CH2— or —(CH2)2— and Y is a lower alkyl group, or a pharmaceutically acceptable salt thereof, which has excellent inhibitory effects on α4 integrin-mediated cell adhesion, and an intermediate useful in the process.
1. A process for preparing a phenylalanine compound of the formula (I):
wherein X 1 is a halogen atom, X 2 is a halogen atom, Q is a group of the formula —CH 2 or —(CH 2 ) 2 — and Y is a C 1-6 alkyl group, or a pharmaceutically acceptable salt thereof, which comprises condensing a compound of the formula (IV)
wherein CO 2 R is a protected carboxyl group and the other symbols are the same as defined above, or a salt thereof, with a compound of the formula (III):
wherein the symbols are the same as defined above, a salt thereof or an acid halide thereof to yield a compound of the formula (II):
wherein the symbols are the same as defined above, and removing the protecting group from the protected carboxyl group of the compound (II), and, optionally, followed by converting the resulting compound into a pharmaceutically acceptable salt.
2. A process for preparing a phenylalanine compound of the formula (I):
wherein X 1 is a halogen atom, X 2 is a halogen atom, Q is a group of the formula —CH 2 — or —(CH 2 ) 2 — and Y is a C 1-6 alkyl group, or a pharmaceutically acceptable salt thereof, which comprises coupling a compound of the formula (VI):
wherein Z is a leaving group, R 1 NH is a protected amino group and CO 2 R is a protected carboxyl group with a compound of the formula (V):
wherein the symbols are the, same as defined above, removing the protecting group from the protected amino group, and, optionally, converting the resulting compound into a salt to yield a compound of the formula (IV):
wherein the symbols are the same as defined above, or a salt thereof, and condensing the compound (IV) or a salt thereof with a compound of the formula (III):
wherein the symbols are the same as defined above, a salt thereof or an acid halide thereof to yield a compound of the formula (II):
wherein the symbols are the same as defined above, removing the protecting group from the protected carboxyl group of the compound (II), and, optionally followed by converting the resulting compound into a pharmaceutically acceptable salt.
3. The process according to claim 1 or 2 , wherein X 1 is a chlorine atom or fluorine atom, X 2 is a chlorine atom or fluorine atom, Y is a C 1-4 group and CO 2 R is a C 2-7 alkoxycarbonyl group.
4. The process according to claim 3 wherein Q is a group of the formula —CH 2 —, Y is a methyl group, ethyl group or n-propyl group, and CO 2 R is a methoxycarbonyl group, ethoxycarbonyl group or t-butoxycarbonyl group.
5. The process according to claim 4 , wherein X 1 is a fluorine atom, Y is a methyl group or ethyl group, and CO 2 R is a methoxycarbonyl group or ethoxycarbonyl group.
6. The process according to claim 4 , wherein X 1 is a fluorine atom, X 2 is a fluorine atom, Y is an ethyl group, and CO 2 R is an ethoxycarbonyl group.
7. The process according to claim 4 , wherein X 1 is a fluorine atom, X 2 is a chlorine atom, Y is an ethyl group, and CO 2 R is a methoxycarbonyl group or an ethoxycarbonyl group.
8. A compound of the formula (IV):
wherein Q is a group of the formula —CH 2 — or —(CH 2 ) 2 —, Y is a C 1-6 alkyl group and CO 2 R is a protected carboxyl group, or a salt thereof.
9. The compound according to claim 8 , wherein Q is a group of the formula —CH 2 —, Y is an ethyl group and CO 2 R is an ethoxycarbonyl group.
10. A process for preparing a compound of the formula (IV):
wherein Q is a group of the formula —CH 2 — or —(CH 2 ) 2 —, Y is a C 1-6 alkyl group and CO 2 R is a protected carboxyl group, or a salt thereof, which comprises coupling a compound of the formula (VI):
wherein Z is a leaving group, R 1 NH is a protected amino group and CO 2 R is the same as defined above with a compound of the formula (V):
wherein the symbols are the same as defined above, removing the amino protecting group, and, optionally, followed by converting the resulting compound into a salt.
11. The process according to claim 10 , wherein Q is a group of the formula —CH 2 —, Y is an ethyl group and CO 2 R is an ethoxycarbonyl group.
12. A compound of the formula (V):
wherein Q is a group of the formula —CH 2 — or —(CH 2 ) 2 — and Y is a C 1-6 alkyl group.
13. The compound according to claim 12 , wherein Q is a group of the formula —CH 2 — and Y is an ethyl group.